A separate prognostic scoring system, Myelofibrosis Secondary to PV and ET-Prognostic Model (MYSEC-PM) [112], was established for SMF, in which only the CALR unmutated genotype was considered a high-risk factor [112]. Here, CALR is linked to essential thrombocythemia.